Efficacy of the Therapeutic Vaccine TG4040 Combined With Pegylated Interferon and Ribavirin in Chronic HCV Patients (HCVac)

This study has been completed.
Sponsor:
Information provided by:
Transgene
ClinicalTrials.gov Identifier:
NCT01055821
First received: January 21, 2010
Last updated: August 9, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)